Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadian Rhythms of Aqueous Humor Dynamics in Humans
NCT00572936Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Mar 2006
- Primary completion
- Nov 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of latanoprost in ocular hypertension, sponsored by University of Nebraska. Primary endpoints: Intraocular Pressure at 2 weeks, Aqueous Humor Flow at 2 weeks and 6 more. Started Mar 2006; status: completed.
02
Drugs
latanoprost
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT00572936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00572936.